Specialty pharmaceutical company Actavis has won FDA approval for abbreviated new drug application (ANDA) of generic equivalent to Endo Health Solutions' Opana ER. Oxymorphone Hydrochloride extended-release tablets, which is available in ...
Tags: FDA, ANDA, Generic Opana ER
Endo Pharmaceuticals has unveiled 7.5mg and 15mg strengths of the reformulated version of OPANA ER with INTAC technology designed to be crush-resistant. The launch makes all the approved strengths of the reformulated version product ...
Tags: Endo, OPANA ER, INTAC technology, 7.5mg and 15mg strengths
America's Impax Laboratories has begun the challenging process against the suit filed by two companies for patent infringement over a generic version of Opana® ER (oxymorphone hydrochloride extended-release) drug. Impax ...